Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
100.57
132.77
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Jazz Pharmaceuticals PLC
Wall Street
Price Targets
JAZZ Price Targets Summary
Jazz Pharmaceuticals PLC
According to Wall Street analysts, the average 1-year price target for
JAZZ
is 184.34 USD
with a low forecast of 129.28 USD and a high forecast of 241.5 USD.
JAZZ Last Price Targets
Jazz Pharmaceuticals PLC
The latest public price target was made on Nov 18, 2024 by
Joel Beatty
from
Robert W. Baird
,
who expects
JAZZ
stock to
rise by 31%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Joel Beatty
Robert W. Baird
|
162
USD
Upside 31% |
1 month ago
Nov 18, 2024
|
Jazz Pharmaceuticals (JAZZ) PT Raised to $162 at Baird
StreetInsider
|
Daniel Busb
RBC Capital
|
179
USD
Upside 45% |
2 months ago
Oct 23, 2024
|
Jazz Pharmaceuticals (JAZZ) PT Raised to $179 at RBC Capital
StreetInsider
|
Annabel Samimy
Stifel Nicolaus
|
230
USD
Upside 86% |
3 months ago
Sep 11, 2024
|
Stifel Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
StreetInsider
|
Andrea Tan
Goldman Sachs
|
169
USD
Upside 37% |
6 months ago
Jun 5, 2024
|
Goldman Sachs Starts Jazz Pharmaceuticals (JAZZ) at Buy
StreetInsider
|
|
Daniel Busb
RBC Capital
|
176
USD
Upside 42% |
7 months ago
May 2, 2024
|
Jazz Pharmaceuticals (JAZZ) PT Lowered to $176 at RBC Capital
StreetInsider
|
David Amsellem
Piper Sandler
|
188
USD
Upside 52% |
9 months ago
Mar 20, 2024
|
Jazz Pharmaceuticals (JAZZ) PT Raised to $188 at Piper Sandler
StreetInsider
|
Price Targets
Operating Income
Forecast
Operating Income Estimate
Jazz Pharmaceuticals PLC
For the last 8 years the
compound annual growth rate for
Jazz Pharmaceuticals PLC's operating income is
3%.
The projected
CAGR
for the next 4 years is
33%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is JAZZ's stock price target?
Price Target
184.34
USD
According to Wall Street analysts, the average 1-year price target for
JAZZ
is 184.34 USD
with a low forecast of 129.28 USD and a high forecast of 241.5 USD.
What is Jazz Pharmaceuticals PLC's Revenue forecast?
Projected CAGR
6%
For the last 8 years the
compound annual growth rate for
Jazz Pharmaceuticals PLC's revenue is
14%.
The projected
CAGR
for the next 4 years is
6%.
What is Jazz Pharmaceuticals PLC's Operating Income forecast?
Projected CAGR
33%
For the last 8 years the
compound annual growth rate for
Jazz Pharmaceuticals PLC's operating income is
3%.
The projected
CAGR
for the next 4 years is
33%.
What is Jazz Pharmaceuticals PLC's Net Income forecast?
Projected CAGR
39%
For the last 8 years the
compound annual growth rate for
Jazz Pharmaceuticals PLC's net income is
3%.
The projected
CAGR
for the next 4 years is
39%.
You don't have any saved screeners yet
